INMD · InMode Ltd.
$15.14
-0.33 (-2.13%)
At close · Jul 29
Market Cap
$889.23M
Shares
57.48M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$15.47
Open$15.27
Day$15.27–15.60
52W$12.72–16.74
Avg vol 30d768K
Short int3.0M · 5.2% float · 4.5d
Short vol25%
Last earningsMay 6, 2026
DataJan 2020–Jul 2026
Up next
Next earnings call
Aug 9, 2026
Est · unconfirmed
· in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Neutral
Sentiment
Bearish
Fundamentals
Strong
Quant / Vol
Moderate
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+8%
above
Price vs 50-day avg
+8%
above
RSI (14)
63
neutral
MACD trend
Negative
52-week position
68%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+6%
trailing
6-month return
−7%
trailing
YTD return
+5%
this year
Relative strength
−14%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $14 › 200d $14 — 200d above 50d
Institutional flow
Distributing
39 of 193 funds reported for Jun 30 · net -509.7K sh shares · +6 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
5.20% of float · ▲ +1.6% MoM · 4.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
193 holders — near 3-yr low, contrarian setup
Squeeze score
67
elevated · 0–100
Fundamentals
Revenue growth
−6%
Y/Y
Gross margin
79%
contracting
EPS growth
−36%
Y/Y
Free cash flow
$84.3M
Balance sheet
$302.5M
net cash
Quant / Vol
risk profile
Volatility
34%
annualized · 1-yr
Max drawdown
−23%
past year
ATR
2.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Mar 31, 2026
Revenues
· 2026
Initiated
$365M – $375M
prior FY $370.5M
midpoint −0.1% Y/Y
Non-GAAP gross margin
· 2026
Non-GAAP
Initiated
74% – 76%
Non-GAAP income from operations
· 2026
Non-GAAP
Initiated
$73M – $78M
Non-GAAP earnings per diluted share
· 2026
Non-GAAP
Initiated
$1.33 – $1.38
Guided vs delivered
· last 1 settled
Revenues
2025
guided $365M – $375M
$370.5M
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+8%
Bullish
Price vs 50-day avg
+8%
Bullish
RSI (14)
63
Neutral
MACD trend
Negative
Bearish
52-week position
68%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $14 › 200d $14 — 200d above 50d
Institutional flow
Distributing
39 of 193 funds reported for Jun 30 · net -509.7K sh shares · +6 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
5.20% of float · ▲ +1.6% MoM · 4.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
193 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $13
Now $15 · 68%
52-wk high $17
vs 200-day avg +8%
vs 50-day avg +8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
INMD
this stock
InMode Ltd.
|
$889.23M | +5.3% | -6.2% | — | 5.2% |
|
ABT
Abbott Laboratories
|
$186.84B | -13.9% | +5.7% | 30.1 | 1.4% |
|
SYK
Stryker Corp
|
$132.87B | -1.1% | +11.2% | 40.1 | 1.8% |
|
MDT
Medtronic plc
|
$111.21B | -8.8% | +8.4% | 23.3 | 1.5% |
|
BSX
Boston Scientific Corp
|
$68.43B | -51.7% | +5.5% | 19.3 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| INMD | +0.7% | +5.7% | -6.9% | +5.8% | +5.3% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | +1.7% | +5.8% | -14.4% | +6.6% | -3.3% |
Key facts
CIK
1742692
CUSIP
M5425M103
13F (30d)
33 filings
33 filers
Visit website
Investor relations